Epithalon vs Vesugen

Overview

Epithalon and Vesugen are both studied in the peptide research space.

Epithalon: A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to activate telomerase and extend lifespan.

Vesugen: A synthetic tripeptide (Lys-Glu-Asp) developed by Russian scientist Vladimir Khavinson, claimed to support vascular health by modulating endothelial gene expression.

Evidence Comparison

Aspect	Epithalon	Vesugen
Evidence Level	Low	Low
Human Studies	5	2
Preclinical Studies	15	8
Total Sources	28	12

Key Differences

Aspect	Epithalon	Vesugen
Category	Longevity	Other
Evidence Strength	Low	Low
Total Sources	28	12
Human Studies	5	2

Summary

• Epithalon: Low evidence with 28 total sources (5 human)
• Vesugen: Low evidence with 12 total sources (2 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.